Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Aug 15;350(Pt 1):207–213.

Phosphoinositide 3-kinase-dependent Ras activation by tauroursodesoxycholate in rat liver.

A K Kurz 1, C Block 1, D Graf 1, S V Dahl 1, F Schliess 1, D Häussinger 1
PMCID: PMC1221243  PMID: 10926845

Abstract

Ursodesoxycholic acid, widely used for the treatment of cholestatic liver disease, causes choleretic, anti-apoptotic and immunomodulatory effects. Here the effects on choleresis of its taurine conjugate tauroursodesoxycholate (TUDC), which is present in the enterohepatic circulation, were correlated with the activation of important elements of intracellular signal transduction in cultured rat hepatocytes and perfused rat liver. TUDC induced a time- and concentration-dependent activation of the small GTP-binding protein Ras and of phosphoinositide 3-kinase (PI 3-kinase) in cultured hepatocytes. Ras activation was dependent on PI 3-kinase activity, without the involvement of protein kinase C- and genistein-sensitive tyrosine kinases. Ras activation by TUDC was followed by an activation of the mitogen-activated protein kinases extracellular-signal-regulated kinase-1 (Erk-1) and Erk-2. In perfused rat liver, PI 3-kinase inhibitors largely abolished the stimulatory effect of TUDC on taurocholate excretion, suggesting an important role for a PI 3-kinase/Ras/Erk pathway in the choleretic effect of TUDC.

Full Text

The Full Text of this article is available as a PDF (173.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alessi D. R., Cuenda A., Cohen P., Dudley D. T., Saltiel A. R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem. 1995 Nov 17;270(46):27489–27494. doi: 10.1074/jbc.270.46.27489. [DOI] [PubMed] [Google Scholar]
  2. Benz C., Angermüller S., Klöters-Plachky P., Sauer P., Stremmel W., Stiehl A. Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes. Eur J Clin Invest. 1998 Jul;28(7):577–583. doi: 10.1046/j.1365-2362.1998.00315.x. [DOI] [PubMed] [Google Scholar]
  3. Beuers U., Nathanson M. H., Boyer J. L. Effects of tauroursodeoxycholic acid on cytosolic Ca2+ signals in isolated rat hepatocytes. Gastroenterology. 1993 Feb;104(2):604–612. doi: 10.1016/0016-5085(93)90433-d. [DOI] [PubMed] [Google Scholar]
  4. Beuers U., Nathanson M. H., Isales C. M., Boyer J. L. Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis. J Clin Invest. 1993 Dec;92(6):2984–2993. doi: 10.1172/JCI116921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beuers U., Spengler U., Kruis W., Aydemir U., Wiebecke B., Heldwein W., Weinzierl M., Pape G. R., Sauerbruch T., Paumgartner G. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology. 1992 Sep;16(3):707–714. doi: 10.1002/hep.1840160315. [DOI] [PubMed] [Google Scholar]
  6. Beuers U., Throckmorton D. C., Anderson M. S., Isales C. M., Thasler W., Kullak-Ublick G. A., Sauter G., Koebe H. G., Paumgartner G., Boyer J. L. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology. 1996 May;110(5):1553–1563. doi: 10.1053/gast.1996.v110.pm8613063. [DOI] [PubMed] [Google Scholar]
  7. Block C., Janknecht R., Herrmann C., Nassar N., Wittinghofer A. Quantitative structure-activity analysis correlating Ras/Raf interaction in vitro to Raf activation in vivo. Nat Struct Biol. 1996 Mar;3(3):244–251. doi: 10.1038/nsb0396-244. [DOI] [PubMed] [Google Scholar]
  8. Boguski M. S., McCormick F. Proteins regulating Ras and its relatives. Nature. 1993 Dec 16;366(6456):643–654. doi: 10.1038/366643a0. [DOI] [PubMed] [Google Scholar]
  9. Burgering B. M., Pronk G. J., van Weeren P. C., Chardin P., Bos J. L. cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J. 1993 Nov;12(11):4211–4220. doi: 10.1002/j.1460-2075.1993.tb06105.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Busch G. L., Schreiber R., Dartsch P. C., Völkl H., Vom Dahl S., Häussinger D., Lang F. Involvement of microtubules in the link between cell volume and pH of acidic cellular compartments in rat and human hepatocytes. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9165–9169. doi: 10.1073/pnas.91.19.9165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Curnock A. P., Knox K. A. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells. Cell Immunol. 1998 Aug 1;187(2):77–87. doi: 10.1006/cimm.1998.1335. [DOI] [PubMed] [Google Scholar]
  12. Davis R. J. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993 Jul 15;268(20):14553–14556. [PubMed] [Google Scholar]
  13. Dudley D. T., Pang L., Decker S. J., Bridges A. J., Saltiel A. R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7686–7689. doi: 10.1073/pnas.92.17.7686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ginès P., Li X., Brown S. E., Nakamura T., Guzelian P. S., Heasley L. E., Schrier R. W., Nemenoff R. A. Inhibitory actions of cyclic adenosine monophosphate and pertussis toxin define two distinct epidermal growth factor-regulated pathways leading to activation of mitogen-activated protein kinase in rat hepatocytes. Hepatology. 1996 May;23(5):1167–1173. doi: 10.1002/hep.510230535. [DOI] [PubMed] [Google Scholar]
  15. Gnudi L., Frevert E. U., Houseknecht K. L., Erhardt P., Kahn B. B. Adenovirus-mediated gene transfer of dominant negative ras(asn17) in 3T3L1 adipocytes does not alter insulin-stimulated P13-kinase activity or glucose transport. Mol Endocrinol. 1997 Jan;11(1):67–76. doi: 10.1210/mend.11.1.9866. [DOI] [PubMed] [Google Scholar]
  16. Güldütuna S., Zimmer G., Imhof M., Bhatti S., You T., Leuschner U. Molecular aspects of membrane stabilization by ursodeoxycholate [see comment]. Gastroenterology. 1993 Jun;104(6):1736–1744. doi: 10.1016/0016-5085(93)90653-t. [DOI] [PubMed] [Google Scholar]
  17. Hallbrucker C., Lang F., Gerok W., Häussinger D. Cell swelling increases bile flow and taurocholate excretion into bile in isolated perfused rat liver. Biochem J. 1992 Feb 1;281(Pt 3):593–595. doi: 10.1042/bj2810593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hawkins M., Hu M., Yu J., Eder H., Vuguin P., She L., Barzilai N., Leiser M., Backer J. M., Rossetti L. Discordant effects of glucosamine on insulin-stimulated glucose metabolism and phosphatidylinositol 3-kinase activity. J Biol Chem. 1999 Oct 29;274(44):31312–31319. doi: 10.1074/jbc.274.44.31312. [DOI] [PubMed] [Google Scholar]
  19. Herrmann C., Martin G. A., Wittinghofer A. Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase. J Biol Chem. 1995 Feb 17;270(7):2901–2905. doi: 10.1074/jbc.270.7.2901. [DOI] [PubMed] [Google Scholar]
  20. Heuman D. M., Mills A. S., McCall J., Hylemon P. B., Pandak W. M., Vlahcevic Z. R. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. Gastroenterology. 1991 Jan;100(1):203–211. doi: 10.1016/0016-5085(91)90602-h. [DOI] [PubMed] [Google Scholar]
  21. Heuman D. M., Pandak W. M., Hylemon P. B., Vlahcevic Z. R. Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology. 1991 Nov;14(5):920–926. doi: 10.1002/hep.1840140527. [DOI] [PubMed] [Google Scholar]
  22. Häfner S., Adler H. S., Mischak H., Janosch P., Heidecker G., Wolfman A., Pippig S., Lohse M., Ueffing M., Kolch W. Mechanism of inhibition of Raf-1 by protein kinase A. Mol Cell Biol. 1994 Oct;14(10):6696–6703. doi: 10.1128/mcb.14.10.6696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Häussinger D., Hallbrucker C., Saha N., Lang F., Gerok W. Cell volume and bile acid excretion. Biochem J. 1992 Dec 1;288(Pt 2):681–689. doi: 10.1042/bj2880681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Häussinger D., Saha N., Hallbrucker C., Lang F., Gerok W. Involvement of microtubules in the swelling-induced stimulation of transcellular taurocholate transport in perfused rat liver. Biochem J. 1993 Apr 15;291(Pt 2):355–360. doi: 10.1042/bj2910355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kitani K., Kanai S. Tauroursodeoxycholate prevents taurocholate induced cholestasis. Life Sci. 1982 Feb 7;30(6):515–523. doi: 10.1016/0024-3205(82)90264-8. [DOI] [PubMed] [Google Scholar]
  26. Kubitz R., D'urso D., Keppler D., Häussinger D. Osmodependent dynamic localization of the multidrug resistance protein 2 in the rat hepatocyte canalicular membrane. Gastroenterology. 1997 Nov;113(5):1438–1442. doi: 10.1053/gast.1997.v113.pm9352844. [DOI] [PubMed] [Google Scholar]
  27. Leuschner U., Fischer H., Kurtz W., Güldütuna S., Hübner K., Hellstern A., Gatzen M., Leuschner M. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology. 1989 Nov;97(5):1268–1274. doi: 10.1016/0016-5085(89)91698-3. [DOI] [PubMed] [Google Scholar]
  28. Liang D., Hagenbuch B., Stieger B., Meier P. J. Parallel decrease of Na(+)-taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes. Hepatology. 1993 Nov;18(5):1162–1166. [PubMed] [Google Scholar]
  29. Lindor K. D., Dickson E. R., Baldus W. P., Jorgensen R. A., Ludwig J., Murtaugh P. A., Harrison J. M., Wiesner R. H., Anderson M. L., Lange S. M. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology. 1994 May;106(5):1284–1290. doi: 10.1016/0016-5085(94)90021-3. [DOI] [PubMed] [Google Scholar]
  30. Martiny-Baron G., Kazanietz M. G., Mischak H., Blumberg P. M., Kochs G., Hug H., Marmé D., Schächtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem. 1993 May 5;268(13):9194–9197. [PubMed] [Google Scholar]
  31. Meier P. J. Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. Am J Physiol. 1995 Dec;269(6 Pt 1):G801–G812. doi: 10.1152/ajpgi.1995.269.6.G801. [DOI] [PubMed] [Google Scholar]
  32. Meijer A. J., Gimpel J. A., Deleeuw G. A., Tager J. M., Williamson J. R. Role of anion translocation across the mitochondrial membrane in the regulation of urea synthesis from ammonia by isolated rat hepatocytes. J Biol Chem. 1975 Oct 10;250(19):7728–7738. [PubMed] [Google Scholar]
  33. Milkiewicz P., Mills C. O., Roma M. G., Ahmed-Choudhury J., Elias E., Coleman R. Tauroursodeoxycholate and S-adenosyl-L-methionine exert an additive ameliorating effect on taurolithocholate-induced cholestasis: a study in isolated rat hepatocyte couplets. Hepatology. 1999 Feb;29(2):471–476. doi: 10.1002/hep.510290215. [DOI] [PubMed] [Google Scholar]
  34. Misra S., Ujházy P., Gatmaitan Z., Varticovski L., Arias I. M. The role of phosphoinositide 3-kinase in taurocholate-induced trafficking of ATP-dependent canalicular transporters in rat liver. J Biol Chem. 1998 Oct 9;273(41):26638–26644. doi: 10.1074/jbc.273.41.26638. [DOI] [PubMed] [Google Scholar]
  35. Nassar N., Horn G., Herrmann C., Scherer A., McCormick F., Wittinghofer A. The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature. 1995 Jun 15;375(6532):554–560. doi: 10.1038/375554a0. [DOI] [PubMed] [Google Scholar]
  36. Noé B., Schliess F., Wettstein M., Heinrich S., Häussinger D. Regulation of taurocholate excretion by a hypo-osmolarity-activated signal transduction pathway in rat liver. Gastroenterology. 1996 Mar;110(3):858–865. doi: 10.1053/gast.1996.v110.pm8608896. [DOI] [PubMed] [Google Scholar]
  37. Ohiwa T., Katagiri K., Hoshino M., Hayakawa T., Nakai T. Tauroursodeoxycholate and tauro-beta-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content. Hepatology. 1993 Mar;17(3):470–476. [PubMed] [Google Scholar]
  38. Pang L., Sawada T., Decker S. J., Saltiel A. R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem. 1995 Jun 9;270(23):13585–13588. doi: 10.1074/jbc.270.23.13585. [DOI] [PubMed] [Google Scholar]
  39. Parquet M., Metman E. H., Raizman A., Rambaud J. C., Berthaux N., Infante R. Bioavailability, gastrointestinal transit, solubilization and faecal excretion of ursodeoxycholic acid in man. Eur J Clin Invest. 1985 Aug;15(4):171–178. doi: 10.1111/j.1365-2362.1985.tb00164.x. [DOI] [PubMed] [Google Scholar]
  40. Poupon R. E., Balkau B., Eschwège E., Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med. 1991 May 30;324(22):1548–1554. doi: 10.1056/NEJM199105303242204. [DOI] [PubMed] [Google Scholar]
  41. Poupon R., Poupon R. E. Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children. Pharmacol Ther. 1995 Apr;66(1):1–15. doi: 10.1016/0163-7258(94)00073-c. [DOI] [PubMed] [Google Scholar]
  42. Queneau P. E., Montet J. C. Hepatoprotection by hydrophilic bile salts. J Hepatol. 1994 Aug;21(2):260–268. doi: 10.1016/s0168-8278(05)80406-4. [DOI] [PubMed] [Google Scholar]
  43. Rubin R. A., Kowalski T. E., Khandelwal M., Malet P. F. Ursodiol for hepatobiliary disorders. Ann Intern Med. 1994 Aug 1;121(3):207–218. doi: 10.7326/0003-4819-121-3-199408010-00009. [DOI] [PubMed] [Google Scholar]
  44. Samuels M. L., Weber M. J., Bishop J. M., McMahon M. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol Cell Biol. 1993 Oct;13(10):6241–6252. doi: 10.1128/mcb.13.10.6241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Schaeffer H. J., Weber M. J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol. 1999 Apr;19(4):2435–2444. doi: 10.1128/mcb.19.4.2435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Schliess F., Kurz A. K., vom Dahl S., Häussinger D. Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver. Gastroenterology. 1997 Oct;113(4):1306–1314. doi: 10.1053/gast.1997.v113.pm9322526. [DOI] [PubMed] [Google Scholar]
  47. Schliess F., Schreiber R., Häussinger D. Activation of extracellular signal-regulated kinases Erk-1 and Erk-2 by cell swelling in H4IIE hepatoma cells. Biochem J. 1995 Jul 1;309(Pt 1):13–17. doi: 10.1042/bj3090013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Schweins T., Geyer M., Scheffzek K., Warshel A., Kalbitzer H. R., Wittinghofer A. Substrate-assisted catalysis as a mechanism for GTP hydrolysis of p21ras and other GTP-binding proteins. Nat Struct Biol. 1995 Jan;2(1):36–44. doi: 10.1038/nsb0195-36. [DOI] [PubMed] [Google Scholar]
  49. Sies H. The use of perfusion of liver and other organs for the study of microsomal electron-transport and cytochrome P-450 systems. Methods Enzymol. 1978;52:48–59. doi: 10.1016/s0076-6879(78)52005-3. [DOI] [PubMed] [Google Scholar]
  50. Taylor S. J., Shalloway D. Cell cycle-dependent activation of Ras. Curr Biol. 1996 Dec 1;6(12):1621–1627. doi: 10.1016/s0960-9822(02)70785-9. [DOI] [PubMed] [Google Scholar]
  51. Wang X., Martindale J. L., Liu Y., Holbrook N. J. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J. 1998 Jul 15;333(Pt 2):291–300. doi: 10.1042/bj3330291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Waskiewicz A. J., Cooper J. A. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr Opin Cell Biol. 1995 Dec;7(6):798–805. doi: 10.1016/0955-0674(95)80063-8. [DOI] [PubMed] [Google Scholar]
  53. Webster C. R., Anwer M. S. Cyclic adenosine monophosphate-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes. Hepatology. 1998 May;27(5):1324–1331. doi: 10.1002/hep.510270519. [DOI] [PubMed] [Google Scholar]
  54. de Rooij J., Bos J. L. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene. 1997 Feb 6;14(5):623–625. doi: 10.1038/sj.onc.1201005. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES